Your Patients Are Struggling to Find Jardiance — Here's How to Help

You prescribe Jardiance (Empagliflozin) because the evidence supports it. For type 2 diabetes, heart failure, and chronic kidney disease, it's one of the most impactful medications in your toolkit. But increasingly, your patients are calling back to say they can't fill it.

Pharmacy stock-outs for brand-name medications like Jardiance are a growing operational challenge for clinical practices. This guide provides actionable steps you and your staff can take to help patients maintain uninterrupted access to their Empagliflozin therapy.

Current Availability Snapshot

Jardiance is not in a formal FDA-listed shortage as of March 2026. Boehringer Ingelheim continues manufacturing, and the product remains in the supply chain. The issue is a mismatch between local pharmacy inventory and surging demand driven by:

• The late-2025 CKD indication expanding the prescribing population to nephrologists
• Continued growth in heart failure prescriptions since the 2022-2023 approvals
• No generic Empagliflozin available in U.S. retail pharmacies despite FDA approval
• Formulary shifts at the start of 2026 creating demand spikes at newly-preferred pharmacies

The result: stock-outs are localized and intermittent but frustratingly common for patients.

Why Your Patients Can't Find It

Understanding the distribution dynamics helps you advise patients more effectively:

Chain Pharmacy Distribution Limitations

Large pharmacy chains (CVS, Walgreens, Rite Aid) typically contract with a single primary wholesaler. When that wholesaler's allocation is exhausted for a particular store, the pharmacy must wait for the next scheduled delivery — which may be days away. High-demand medications like Jardiance can sell through inventory faster than replenishment cycles.

Insurance-Driven Pharmacy Routing

Patients are often directed to specific pharmacies by their insurance plans (preferred pharmacies, specialty pharmacy requirements). If those preferred pharmacies are large chains experiencing the distribution constraints described above, patients have limited options without paying out-of-network prices.

Patient Timing

Many patients attempt to fill prescriptions late in the week or wait until they've completely run out. By then, pharmacy stock may already be depleted from earlier fills. Proactive refill timing — 5 to 7 days before the last dose — significantly improves success rates.

What Providers Can Do: 5 Actionable Steps

Step 1: Check Stock Before You Prescribe

Use Medfinder for Providers to verify pharmacy-level availability before sending a prescription. This takes seconds and prevents the scenario where a patient arrives at the pharmacy only to be told it's out of stock. Integrate this check into your prescribing workflow, especially for brand-name medications without generic equivalents.

Step 2: Send to Independent Pharmacies When Possible

Independent pharmacies work with multiple wholesalers and can often source Jardiance when chains cannot. If you have relationships with local independents, consider routing Jardiance prescriptions there by default. Many independent pharmacies will also hold stock for patients who order ahead.

Step 3: Recommend Mail-Order for Maintenance Therapy

For patients on stable Jardiance therapy, mail-order pharmacy is one of the most reliable fulfillment channels. Most commercial and Medicare Part D plans offer 90-day mail-order options. Benefits include:

• Bulk ordering reduces stock-out risk
• Automatic refill scheduling prevents gaps
• Often lower per-fill copays compared to retail

Encourage your clinical team to discuss mail-order options at every visit for patients on chronic Jardiance therapy.

Step 4: Maintain a Bridge Strategy

When a patient can't fill their prescription immediately, have a plan ready:

• Samples: If you receive manufacturer samples of Jardiance, maintain a small stock for urgent bridge situations.
• Within-class substitution: Have a pre-identified alternative (typically Dapagliflozin/Farxiga) ready as a temporary switch. Document the rationale and plan to switch back when Jardiance is available.
• Combination products: Synjardy (Empagliflozin + Metformin), Glyxambi (Empagliflozin + Linagliptin), or Trijardy XR may be available when standalone Jardiance is not.

Step 5: Proactively Educate Patients

Set expectations at the point of prescribing. Let patients know that:

• Jardiance may not always be immediately available at every pharmacy
• They should start the refill process 5-7 days early
• They can use Medfinder to check stock before going to the pharmacy
• If they can't find it, they should call your office rather than skipping doses

Providing this guidance proactively reduces urgent phone calls and prevents treatment interruptions.

Alternatives to Consider

When a temporary or longer-term switch is needed, the following SGLT2 inhibitors are the most appropriate substitutes:

• Farxiga (Dapagliflozin): 5 mg or 10 mg daily. FDA-approved for T2DM, HFrEF, and CKD. Most similar indication profile to Jardiance.
• Invokana (Canagliflozin): 100 mg or 300 mg daily. FDA-approved for T2DM and diabetic nephropathy. Note the boxed warning for lower limb amputation risk.
• Steglatro (Ertugliflozin): 5 mg or 15 mg daily. T2DM only — lacks heart failure and CKD indications.

For a detailed comparison, see our clinical overview: Jardiance shortage — what prescribers need to know.

Workflow Tips for Your Practice

• Add availability checks to your e-prescribing workflow: Before sending a Jardiance prescription electronically, verify stock at the destination pharmacy using Medfinder for Providers.
• Flag Jardiance patients in your EHR: Create an alert or label for patients on Empagliflozin so refill-related calls are prioritized and routed to the right staff member.
• Pre-authorize alternatives: If your patient is on Jardiance and their insurer covers Farxiga, consider obtaining advance approval for Farxiga as a backup. This eliminates PA delays if a switch becomes necessary.
• Coordinate with your pharmacy partners: If you work closely with specific pharmacies, ask them to flag when Jardiance inventory drops below a threshold. Some pharmacy management systems support automated alerts.
• Share patient-facing resources: Direct patients to our guides on finding Jardiance in stock and saving money on Jardiance.

Final Thoughts

Jardiance availability challenges in 2026 are a supply-demand problem, not a clinical one. The medication is being manufactured and distributed — the gaps are at the pharmacy shelf level. By integrating stock-checking tools like Medfinder for Providers into your workflow, maintaining bridge strategies, and proactively educating patients, you can keep your patients on their therapy without disruption.

Treatment continuity matters. A few minutes of proactive planning in your office saves your patients hours of frustration at the pharmacy counter.